The thing with partnership is that only 27.5m was earned. The rest has not been earned and is conditional. Partnership can be cancelled in the future. So market credits a portion of the partnership accordingly
Kash, i agree with you that the problem is lack of demand. 3 lines can supply a few hundred thousand patients. But at best we have a few thousand users now. In other words supply outstrip current demand by 100 times
Penny don't you think Afrezza alone is worth at least $12? If there is a buyout of Afrezza, it would bet $15+. Whole mnkd $20+
They can't short the private 9m shares but nothing stops them from shorting the commons out in the market. So what is the big deal about retirimg the 9m shares?
Seer, if you have a call option, say 4 months to expiration, and you convert the option to commons, does your basis starts all over or does it continue from the day you bought the option?
This is not the right place to voice your opinion and expect to be heard by management. Why don't you call them up or why didn't attend the last CC to voice your opinion?
Regarding AC1, about 6.2 is prediabetic. With some persistence i am sure your dad can bring it down to 6.2. Sam Finta says every 1 point you being down, i significantly reduces stress on your organs
During Q1 or was it Q2, Al said they would likely let SNY to manufacture afrezza outside of Danburry plant especially outside of USA. Mankind does not want to be a manufacturer beyond Danburry
Sentiment: Strong Buy
johnny, you wrote "If it goes to 30 dollars, all you have to do is click the sell button and your shares are released"
Technically, it does not work like that. Your sale transaction takes 3 days to settle. The broker will temporarily credit your account the moment you sold your stocks. But if the settlement fails, they take the credit back from your account. How the settlement works is this. Say, the day before your shares were loaned out. Your collateral is adjusted the night before (say $6 a share). Say, the next day there were a buyout at $30 a share. You hit your sell button to sell your shares at $30. You temporarily get a credit of $30/share. The settlement involves recalling the loaned shares (since you loaned it out the day before), request the borrower to return the shares. If the borrower can return the shares, the transaction is settled. If the borrow decided to walk away, the broker will attempt to sell his/her other stocks (if any, like a force liquidation) as an attempt to recover as much money as possible. If the borrower had nothing (no cash nor other equity), the settlement fails. You may not get your gain of $24 (30 minus 6). You get at least $6 because of the collateral.
You are in control until you are not OR until something bad happens. If a default happens, you may not have the same control.
The purpose of settlement is to locate the borrower, recall the loaned shares, clear your sale transaction, get you paid, etc.
If mnkd ever pops big (i.e. from 6 to 30) and shorts go bankrupt, your loaned shares will be defaulted and you will not get your $30. You recover your $6, but not any gain. Shorts walk away. Think of it like the Greece situation or the real estate default.
Credit should also be given to Eric Fenar who has been unselfishly educating as many diabetics as he possibly can through personal contacts, YouTube, Twitter etc.
Each party can cancel the agreement. Imagine Mankind pulls the plug after afrezza achieves blockbuster status. SNY will be left with nothing after having done all the hard work launching afrezza world wide.
If they had a deal, they are required by regulation to disclose any and all material event/deal
Thanks kevin. Your recent posts are more refreshing than your same old same old buyout guesses
Sentiment: Strong Buy